FDA Approved: RIFAMPIN — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

FDA approved a supplemental application for Rifampin from Chartwell RX, LLC under an ANDA. This confirms approval of a generic Rifampin product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Disease
• Tuberculosis

Drugs mentioned

• RIFAMPIN (RIFAMPIN)

Snippet

SUPPL AP for RIFAMPIN (RIFAMPIN)